Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs REX AI Equity Premium Income ETF (AIPI) Price & Performance

Abeona Therapeutics IncTrade
REX AI Equity Premium Income ETFTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs REX AI Equity Premium Income ETF — how do they compare? Abeona Therapeutics Inc trades at $7.45 (market cap $421.19M), while REX AI Equity Premium Income ETF trades at $37.4. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, REX AI Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.

ABEOAIPI
Market Cap
$421.19M
Sector
HealthIncome / Options Overlay
52-Week High
$7.45$44.93
52-Week Low
$4.17$32.45
Enterprise Value
$276.10M

Returns comparison

Trailing returns across standard periods

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About REX AI Equity Premium Income ETF

AIPI provides exposure to leading artificial intelligence firms while seeking to generate monthly income. It uses a covered call strategy to capture premiums from the volatility of AI-related stocks.

Read more on AIPI